RxRevu and FDB Partner to Accelerate Delivery of Real-Time Prescription Benefit Data to the Point of Care

RxRevu and FDB team up to accelerate delivery of Rx benefit data at the POC

RxRevu, the leading provider of integrated decision support tools which improve patient access to care, and FDB (First Databank, Inc.), the leading provider of drug and medical device knowledge that helps healthcare professionals make precise decisions, today announced a partnership to bring robust prescription cost and coverage data to hospitals, health systems, and electronic health record (EHR) vendors across the United States.

“The RxRevu and FDB partnership is an exciting step forward in delivering real-time, patient-specific cost and coverage data where it matters most,” said Kyle Kiser, Chief Executive Officer at RxRevu. “With the inclusion of FDB’s vast customer network, we have an opportunity to impact more patients and improve existing workflows for providers nationwide.”

RxRevu’s Real-Time Prescription Benefit solution – SwiftRx Direct – delivers patient-specific pharmacy benefit information to EHR workflows via direct connections with prominent pharmacy benefit managers. The technology displays accurate, real-time data at the point of prescribing, enabling physicians to quickly and easily find affordable alternatives for costly medications specific to a patient’s health needs and insurance benefits.

FDB, part of the Hearst Health network, curates the industry’s most robust database of clinical drug information. FDB’s drug knowledge is deployed by the majority of hospitals, physician practices, pharmacies, payers, and other healthcare entities within their information systems and is used by clinicians and healthcare decision-makers every day. By leveraging FDB’s commercial channels, RxRevu will expand the delivery of its prescription coverage and cost data as a supplementary service. As a result, prescribers will gain access to previously inaccessible drug information, which will help drive patient cost savings and reduce administrative burden.

“We are excited to add this valuable service to our suite of offerings,” said FDB President Bob Katter. “RxRevu’s real-time price transparency and coverage capabilities complement our overall mission by helping health systems improve the prescribing experience and ultimately drive increased medication adherence and patient safety.”

FDB will offer RxRevu’s prescription cost and coverage solution to current and future hospital, health system, and EHR clients. Those interested in leveraging FDB’s drug knowledge capabilities and/or RxRevu’s prescription decision support tools are encouraged to contact Steve Normile, director of strategic alliances for FDB, at snormile@fdbhealth.com.